Evidence map›Paper›PMID 34703398›Full record

ArticleWorld journal of nuclear medicine

Andres Damian, Maria M Pineyro, Adriana Quagliata, Mariana Risso, Paula Montiglia, Ramiro Lima, Omar Alonso

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of nuclear medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026
    Review
  2. Review
  3. DRD2 expression based onEndocrine · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andres DamianUruguayan Centre of Molecular Imaging, University of the Republic (UdelaR), Montevideo, Uruguay.
Maria M PineyroDepartment of Endocrinology, Clinical Hospital, University of the Republic (UdelaR), Montevideo, Uruguay.
Adriana QuagliataUruguayan Centre of Molecular Imaging, University of the Republic (UdelaR), Montevideo, Uruguay.
Mariana RissoDepartment of Endocrinology, Clinical Hospital, University of the Republic (UdelaR), Montevideo, Uruguay.
Paula MontigliaDepartment of Endocrinology, Clinical Hospital, University of the Republic (UdelaR), Montevideo, Uruguay.
Ramiro LimaDepartment of Neurosurgery, Clinical Hospital, University of the Republic (UdelaR), Montevideo, Uruguay.
Omar AlonsoUruguayan Centre of Molecular Imaging, University of the Republic (UdelaR), Montevideo, Uruguay.
Universidad de la República · UYCentro Uruguayo de Imagenología Molecular · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some studies have assessed the expression of dopaminergic dopamine 2 (D2)/3 receptors in prolactinomas and nonfunctioning pituitary adenomas (NFPA) by positron emission tomography/computed tomography (PET/CT) with

Indexed as

11C-methionine18F-fallypridenonfunctioning adenomapositron emission tomographyprolactinoma

Identifiers

PMID34703398
PMCPMC8488883
OpenAlexW3138318023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.